Myomo, Inc.

Equities

MYO

US62857J2015

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:00 2024-04-26 pm EDT			Pre-market 07:49:24 am
3.43 ^USD	+0.29%		3.37	-1.75%

Mar. 28	Myomo, Inc. Appoints Heather Getz as Class II Director and Chair of Audit Committee	CI
Mar. 07	Transcript : Myomo, Inc., Q4 2023 Earnings Call, Mar 07, 2024

Myomo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023

March 07, 2024 at 04:10 pm EST

Myomo, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 19.24 million compared to USD 15.56 million a year ago. Net loss was USD 8.15 million compared to USD 10.72 million a year ago.

Basic loss per share from continuing operations was USD 0.28 compared to USD 1.52 a year ago.

Latest news about Myomo, Inc.

Myomo, Inc. Appoints Heather Getz as Class II Director and Chair of Audit Committee	Mar. 28	CI
Transcript : Myomo, Inc., Q4 2023 Earnings Call, Mar 07, 2024	Mar. 07
Earnings Flash (MYO) MYOMO Reports Q4 Revenue $4.8M, vs. Street Est of $4.8M	Mar. 07	MT
Myomo, Inc. Provides Earnings Guidance for the First Quarter of 2024	Mar. 07	CI
Myomo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
Myomo, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 07	CI
Myomo Completes $6 Million Share Offering	Jan. 19	MT
Myomo to Sell $6 Million of Common Shares in Registered Direct Offering	Jan. 17	MT
Myomo, Inc. Provides Earnings Guidance for the Fourth Quarter of 2023	Jan. 17	CI
Certain Warrants of Myomo, Inc. are subject to a Lock-Up Agreement Ending on 29-NOV-2023.	Nov. 28	CI
Myomo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI
Earnings Flash (MYO) MYOMO Posts Q3 Revenue $5.1M, vs. Street Est of $4.2M	Nov. 07	MT
Transcript : Myomo, Inc., Q3 2023 Earnings Call, Nov 07, 2023	Nov. 07
Myomo, Inc. Provides Revenue Guidance for the Full Year of 2023	Nov. 07	CI
Myomo, Inc. Announces CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro for Review at the Upcoming HCPCS Public Meeting	Nov. 06	CI
Myomo Closes Offering of 7.33 Million Shares	23-08-29	MT
Sector Update: Health Care Stocks Mixed Pre-Bell Friday	23-08-25	MT
Myomo Plans Public Offering of Common Shares	23-08-25	MT
Transcript : Myomo, Inc., Q2 2023 Earnings Call, Aug 09, 2023	23-08-09
Earnings Flash (MYO) MYOMO Posts Q2 Revenue $6M, vs. Street Est of $5.6M	23-08-09	MT
Myomo, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
Centers for Medicare and Medicaid Services Accepts Myomo, Inc.'s Application to Classify the MyoPro as A Brace	23-07-03	CI
Maxim Initiates Myomo at Buy With $2 Price Target	23-05-25	MT
Transcript : Myomo, Inc., Q1 2023 Earnings Call, May 10, 2023	23-05-10
Earnings Flash (MYO) MYOMO Posts Q1 Revenue $3.45M, vs. Street Est of $3.34M	23-05-10	MT

Chart Myomo, Inc.

Duration

Period

More charts

Company Profile

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. MyoPro senses a patientâs own electromyography (EMG) signals through non-invasive sensors on the arm, and can restore an individualâs ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. It provides devices directly to patients and bill their insurance companies directly. It also sells its products through various other sales channels, including through orthotics and prosthetics providers, the veteranâs administration, and others.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-14 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Myomo, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.43 USD

Average target price

6.312 USD

Spread / Average Target

+84.04%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
MYOMO, INC.	-31.54%	98.78M
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution